Hitoshi Kashiwagi

681 citations

48 papers · 493 indexed · h-index 12

Co-authors: Fumitaka Ushikubi Yoh Takekuma Mitsuru Sugawara Shungo Imai Koh-ichi Yuhki Shuh Narumiya Takayuki Miyai Takayuki Fujino
Topics: Inflammatory mediators and NSAID effects (10 papers)Antimicrobial Resistance in Staphylococcus (9 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)
Cited by: Biochemistry Pharmacology Toxicology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Scientific Reports
Partner nations: Japan United States Bangladesh

In The Last Decade

Hitoshi Kashiwagi

44 papers receiving 491 citations

Peers

Countries citing papers authored by Hitoshi Kashiwagi

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Kashiwagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kashiwagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kashiwagi more than expected).

Fields of papers citing papers by Hitoshi Kashiwagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Kashiwagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kashiwagi. The network helps show where Hitoshi Kashiwagi may publish in the future.

Co-authorship network of co-authors of Hitoshi Kashiwagi

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Kashiwagi. A scholar is included among the top collaborators of Hitoshi Kashiwagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Kashiwagi. Hitoshi Kashiwagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative analysis of communication changes in online medication counseling using the Roter Interaction System 2023 ·Research in Social and Administrative Pharmacy ·Ayako Mori,Izumi Kato,Katsuya Narumi,Yoh Takekuma,Hitoshi Kashiwagi,Yuki Sato,Mitsuru Sugawara,(unknown)	1
2	Monitoring Salivary Concentrations of Tedizolid and Linezolid Using Rats 2023 ·European Journal of Drug Metabolism and Pharmacokinetics ·Yuki Inoue,Yuki Sato,Hitoshi Kashiwagi,(unknown),Mitsuru Sugawara,Yoh Takekuma	2
3	Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia 2023 ·European Journal of Clinical Pharmacology ·Yuki Inoue,Yoh Takekuma,Takayuki Miyai,Hitoshi Kashiwagi,Yuki Sato,Mitsuru Sugawara,Shungo Imai	9
4	Risk Factor Analysis of Vancomycin-Induced Nephrotoxicity in Paediatric Patients Aged 0–1 Year Using Japanese Medical Database 2023 ·Biological and Pharmaceutical Bulletin ·Takayuki Miyai,Yoh Takekuma,Hitoshi Kashiwagi,Yuki Sato,(unknown),Mitsuru Sugawara,Shungo Imai	2
5	Hepatic drug metabolism in older people with body composition changes 2022 ·Geriatrics and gerontology international ·(unknown),(unknown),Yasushi Miyamoto,Shungo Imai,Hitoshi Kashiwagi,(unknown),Mitsuru Sugawara,Yoh Takekuma	3
6	Using Japanese big data to investigate novel factors and their high‐risk combinations that affect vancomycin‐induced nephrotoxicity 2022 ·British Journal of Clinical Pharmacology ·Shungo Imai,(unknown),Takayuki Miyai,Hitoshi Kashiwagi,Yuki Sato,Mitsuru Sugawara,Yoh Takekuma	19
7	Facilitation of colonic T cell immune responses is associated with an exacerbation of dextran sodium sulfate–induced colitis in mice lacking microsomal prostaglandin E synthase-1 2022 ·Inflammation and Regeneration ·Fumiaki Kojima,(unknown),(unknown),Hitoshi Kashiwagi,Makoto Kubo,Masaki Nakamura,(unknown),Yoshitaka Imamichi,Koh‐ichi Yuhki,Fumitaka Ushikubi,Hidero Kitasato,Takafumi Ichikawa	16
8	A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database 2021 ·Expert Opinion on Drug Safety ·Shungo Imai,Kenji Momo,Hitoshi Kashiwagi,Yuki Sato,Takayuki Miyai,Mitsuru Sugawara,Yoh Takekuma	1
9	Factors affecting creatine phosphokinase elevation during daptomycin therapy using a combination of machine learning and conventional methods 2021 ·British Journal of Clinical Pharmacology ·Shungo Imai,Hitoshi Kashiwagi,Yuki Sato,Takayuki Miyai,Mitsuru Sugawara,Yoh Takekuma	11
10	Investigation of the risk factors of vomiting during linezolid therapy: a retrospective observational study 2021 ·European Journal of Clinical Pharmacology ·(unknown),Shungo Imai,Hitoshi Kashiwagi,Yuki Sato,Mitsuru Sugawara,Yoh Takekuma	2
11	Nonsteroidal anti‐inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them 2020 ·Pharmacoepidemiology and Drug Safety ·Shungo Imai,Kenji Momo,Hitoshi Kashiwagi,Takayuki Miyai,Mitsuru Sugawara,Yoh Takekuma	5
12	Comparison of interactions between warfarin and cephalosporins with and without the N-methyl-thio-tetrazole side chain 2020 ·Journal of Infection and Chemotherapy ·Shungo Imai,(unknown),Kenji Momo,Hitoshi Kashiwagi,Yuki Sato,Takayuki Miyai,Mitsuru Sugawara,Yoh Takekuma	6
13	Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice 2020 ·PLoS ONE ·Shungo Imai,Yoh Takekuma,Hitoshi Kashiwagi,Takayuki Miyai,Masaki Kobayashi,Ken Iseki,Mitsuru Sugawara	31
14	A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study 2020 ·Antibiotics ·Takayuki Miyai,Shungo Imai,Hitoshi Kashiwagi,Yuki Sato,(unknown),Kenji Yoshida,(unknown),(unknown),Takashi Tsujimoto,(unknown),(unknown),(unknown),Yoshikazu Goto,Yoh Takekuma,Mitsuru Sugawara	17
15	Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database 2020 ·Journal of Pharmaceutical Health Care and Sciences ·Shungo Imai,Kenji Momo,Hitoshi Kashiwagi,Takayuki Miyai,Mitsuru Sugawara,Yoh Takekuma	11
16	Diethylstilbestrol administration inhibits theca cell androgen and granulosa cell estrogen production in immature rat ovary 2017 ·Scientific Reports ·Yoshitaka Imamichi,Toshio Sekiguchi,Takeshi Kitano,Takashi Kajitani,Reiko Okada,(unknown),Kaoru Miyamoto,Junsuke Uwada,Satoru Takahashi,Takahiro Nemoto,(unknown),Md. Rafiqul Islam Khan,Tariqul Islam,Koh‐ichi Yuhki,Hitoshi Kashiwagi,Fumitaka Ushikubi,Nobuo Suzuki,Takanobu Taniguchi,Takashi Yazawa	19
17	The intrinsic prostaglandin E2–EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice 2012 ·Kidney International ·Naoki Nakagawa,Koh-ichi Yuhki,(unknown),Takayuki Fujino,Osamu Takahata,Maki Kabara,(unknown),(unknown),Hitoshi Kashiwagi,Naoyuki Hasebe,Kenjiro Kikuchi,Yukihiko Sugimoto,Shuh Narumiya,Fumitaka Ushikubi	67
18	Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies 2010 ·Pharmacology & Therapeutics ·Koh-ichi Yuhki,(unknown),Hitoshi Kashiwagi,(unknown),Takayuki Fujino,Shuh Narumiya,Fumitaka Ushikubi	73
19	Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation 2010 ·Thrombosis and Haemostasis ·Koh‐ichi Yuhki,(unknown),Takehiro Yamada,(unknown),(unknown),Kōji Takayama,(unknown),Akitoshi Yoshida,Shuh Narumiya,(unknown),Hitoshi Kashiwagi,Fumitaka Ushikubi	37
20	Septicemia due to Aeromonas hydrophila in patients with acute leukemia: clinical and bacteriologial features and a possible beneficial effect on hematological remission. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown),Hitoshi Kashiwagi,(unknown),Yukihiko Adachi,Tomohisa Nomura	1

About Hitoshi Kashiwagi

Hitoshi Kashiwagi is a scholar working on Pharmacology, Toxicology and Geriatrics and Gerontology, having authored 48 papers that have together received 493 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Biochemistry (85 citations), Pharmacology (150 citations) and Toxicology (25 citations). Hitoshi Kashiwagi has collaborated with scholars based in Japan, United States and Bangladesh. Frequent co-authors include Fumitaka Ushikubi, Yoh Takekuma, Mitsuru Sugawara, Shungo Imai, Koh-ichi Yuhki, Shuh Narumiya, Takayuki Miyai, Takayuki Fujino, Yuki Sato and Koh‐ichi Yuhki. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact